David Tyronne Howton, Jr
2014
In 2014, David Tyronne Howton, Jr earned a total compensation of $1.7M as Senior Vice President, General Counsel and Corporate Secretary at Sarepta Therapeutics, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $133,758 |
|---|---|
| Option Awards | $1,155,231 |
| Salary | $393,407 |
| Other | $12,518 |
| Total | $1,694,914 |
Howton received $1.2M in option awards, accounting for 68% of the total pay in 2014.
Howton also received $133.8K in non-equity incentive plan, $393.4K in salary and $12.5K in other compensation.
Rankings
In 2014, David Tyronne Howton, Jr's compensation ranked 5,234th out of 13,032 executives tracked by ExecPay. In other words, Howton earned more than 59.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,234 out of 13,032 | 60th |
Division Manufacturing | 1,868 out of 4,967 | 62nd |
Major group Chemicals And Allied Products | 627 out of 1,690 | 63rd |
Industry group Drugs | 479 out of 1,369 | 65th |
Industry Pharmaceutical Preparations | 379 out of 1,042 | 64th |
Source: SEC filing on April 27, 2017.
Howton's colleagues
We found five more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2014.
2014
Christopher Garabedian
Sarepta Therapeutics
Chief Executive Officer
2014
Arthur Krieg
Sarepta Therapeutics
Chief Scientific Officer
2014
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2014
Edward Kaye
Sarepta Therapeutics
Chief Executive Officer
2014
Jayant Aphale
Sarepta Therapeutics